Irvine, CA - A court injunction preventing the sale of Medtronic's CoreValve in Germany went into effect yesterday, the manufacturer of the CoreValve's chief competitor, Edwards Lifesciences, ...
MINNEAPOLIS – Medtronic, Inc.today announced it has received CE (Conformité Européenne) Mark for the Medtronic CoreValve® System to be delivered using direct aortic access. The Medtronic CoreValve ...
Medtronic's CoreValve system today gained a second indication from the FDA for use in patients with severe aortic stenosis who are at high risk for surgery. The transcatheter aortic valve replacement ...
Medtronic's CoreValve transcatheter aortic valve replacement system continued to report positive data at two years for high-risk patients. The study shows the efficacy of TAVR for high-risk patients ...
FRESNO, Calif. (KFSN) -- Severe aortic stenosis is a heart condition that happens when the aortic valve doesn't open properly. Patients used to have to undergo an invasive, open-heart surgery to ...
Minneapolis, MN - The long-awaited US trial of the CoreValve transcatheter aortic-valve system is set to begin soon now that the FDA has granted Medtronic an investigational device exemption (IDE) for ...
DUBLIN and CHICAGO - April 3, 2016 - Medtronic plc (MDT) today announced new data from the High Risk Study of the CoreValve U.S. Pivotal Trial that show superior clinical outcomes for transcatheter ...
Medtronic says it plans to appeal the $73.5 million jury verdict that its CoreValve transcatheter aortic valve system infringes a U.S. Andersen patent owned by Edwards Lifesciences. The CoreValve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results